Search Menu
Photonics Media Photonics Buyers' Guide Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook
More News

ICN Pharmaceuticals, U of Michigan to Study Lasers for Skin Diseases

Facebook Twitter LinkedIn Email Comments
ANN ARBOR, Mich., May 24 -- The University of Michigan has received funding from ICN Pharmaceuticals Inc. for a three-year study examining the medical benefits of non-ablative lasers. ICN currently markets two non-ablative lasers, NLite System and Cool Touch, to treat facial wrinkles.

Non-ablative lasers "could represent a new paradigm in the treatment of photoaging problems and skin diseases -- a non-invasive, relatively pain-free, effective treatment for a range of issues that were seen, not so long ago, as very difficult to treat," said John Voorhees, chair and professor of dermatology in the University of Michigan Medical School.
May 2002
News & Featureslasers

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.